The future of health is: Measure Understand Correct Optimise
All GLP-1 medications have been proven to be effective for diabetes, and some have been studied and proven to be effective for weight loss as well
Association between glucagon-like peptide-1 receptor agonists and ovarian cancer survival: a population-based cohort study
ABSTRACT: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/GLP-1 RAs are common therapies for managing diabetes and obesity, but gastrointestinal (GI) adverse effects (AEs) such as nausea, vomiting, diarrhea, and constipation frequently limit therapy
The Gut-Brain Connection Slowed digestive processes mean stool stays in your body longer than it otherwise would before being excreted
While some providers recommend brushing before dosing to prepare the mucosa, aggressive brushing can actually cause bleeding or irritation that changes absorption patterns